ABBOTT LABORATORIES reported first-quarter financial results that exceeded Wall Street estimates, driven by the strength of its medical device division and its strategic expansion into the cancer diagnostics market.

A logo of Abbott is displayed at the company's booth during the 8th China International Import Expo in Shanghai, China, on November 6, 2025. REUTERS/Maxim Shemetov/File Photo